Q2 2025 Curis Inc Earnings Call Transcript

Aug 5, 2025 / 12:30 PM GMT

Release Date Price: €1.43 (+2.14%)

Transcript 10-Q8-K

Key Points

Positve

Curis Inc (CRIS) is making steady progress in its Taga lymphoma study, which could support accelerated submissions in the US and Europe.
The company has engaged with key opinion leaders who are excited about expanding the use of emovussertib into additional indications.
Curis Inc (CRIS) reported a reduced net loss of $8.6 million for Q2 2025, compared to $11.8 million in the same period in 2024.
Research and development expenses decreased significantly, indicating cost management improvements.
The company completed a registered direct offering and concurrent private placement, raising approximately $6 million.

Negative

Curis Inc (CRIS) reported a net loss of $8.6 million for the second quarter of 2025.
The company's cash and cash equivalents stand at $10.1 million, which may only fund operations into the first quarter of 2026.
Enrollment in the Taga lymphoma study is progressing slowly due to the ultra-rare population being targeted.
The company faces competition from other BTK inhibitors and degraders in the evolving CLL treatment landscape.
Curis Inc (CRIS) is operating in a challenging financial environment, which may impact its ability to fund multiple trials simultaneously.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

CRIS.OQ - Curis Inc
Q2 2025 Curis Inc Earnings Call
Aug 05, 2025 / 12:30PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good morning and welcome to Curious's 2nd quarter 2025 business update call. All participants will be in listen-only mode. Should you need assistance, please signal a conference specialist by pressing the star key followed by 0. After the company's prepared remarks, call participants will have an opportunity to ask questions. To ask a question, you may press star, then 1 on your touch tone phone. To withdraw your question, please press 2.

Please be advised this call is being recorded today, Tuesday, August 5, 2025. I would now like to turn the conference over to Diantha Duvall, Curri's Chief Financial Officer. Diana, please go ahead.

--------------------------------------------------------------------------------
Unidentified_2 [2]

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.